NRSNW
Income statement / Annual
Last year (2023), NeuroSense Therapeutics Ltd.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, NeuroSense Therapeutics Ltd.'s net income was -$10.11 M.
See NeuroSense Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$97,000.00 |
$89,000.00 |
$3,000.00 |
$3,000.00 |
$0.00 |
| Gross Profit |
-$97,000.00 |
-$89,000.00 |
-$3,000.00 |
-$3,000.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$7.27 M
|
$6.42 M
|
$3.08 M
|
$2.50 M
|
$898,000.00
|
| General & Administrative
Expenses |
$4.78 M
|
$7.14 M
|
$2.51 M
|
$393,000.00
|
$337,000.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$4.78 M
|
$7.14 M
|
$2.51 M
|
$393,000.00
|
$337,000.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$10.29 M |
$13.55 M |
$5.59 M |
$2.89 M |
$1.24 M |
| Cost And Expenses |
$10.29 M |
$13.55 M |
$5.59 M |
$2.89 M |
$1.24 M |
| Interest Income |
$178,000.00 |
$91,000.00 |
$0.00 |
$61,000.00 |
$18,000.00 |
| Interest Expense |
$550,000.00 |
$15,000.00 |
$1.15 M |
$1,000.00 |
$5,000.00 |
| Depreciation &
Amortization |
$21,000.00
|
$89,000.00
|
$3,000.00
|
$3,000.00
|
$1.24 M
|
| EBITDA |
-$10.63 M
|
-$13.38 M
|
-$2.88 M
|
-$2.83 M
|
-$1.25 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$769,000.00
|
$1.21 M
|
$1.55 M
|
$60,000.00
|
$13,000.00
|
| Income Before Tax |
-$11.28 M |
-$12.34 M |
-$4.04 M |
-$2.83 M |
-$1.22 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$1.14 M |
-$1.55 M |
$1,000.00 |
$5,000.00 |
| Net Income |
-$10.11 M |
-$11.20 M |
-$2.50 M |
-$2.83 M |
-$1.23 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.83 |
-0.97 |
-1.29 |
-1.46 |
-0.63 |
| EPS Diluted |
-0.83 |
-0.97 |
-1.29 |
-1.46 |
-0.63 |
| Weighted Average Shares
Out |
$13.64 M
|
$11.50 M
|
$1.94 M
|
$1.94 M
|
$1.94 M
|
| Weighted Average Shares
Out Diluted |
$13.64 M
|
$11.50 M
|
$1.94 M
|
$1.94 M
|
$1.94 M
|
| Link |
|
|
|
|
|
